Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

NCT02686619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Cyclosporine
DRUG: Daclizumab
DRUG: Mycophenoate Mofetil
DRUG: Prednisolone
DRUG: Sirolimus

Sponsor

Hoffmann-La Roche